Clinical Trial: ECOG-ACRIN EA8191

ECOG-ACRIN EA8191

Status: Open

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

Eligible for screening study DCP 001

Pre-Registration QOLs - To be completed after consent, prior to registration.